前立腺特異抗原（PSA）検査市場-検査タイプ別、用途別、最終用途別-世界予測、2023-2032年

前立腺特異抗原（PSA）検査市場規模は、確認検査を含む包括的診断アプローチへの継続的シフトに牽引され、2023年から2032年にかけてCAGR 8.3％で拡大すると予測されます。

近年、世界中のヘルスケアプロバイダーは、前立腺特異抗原（PSA）検査をより広範な診断戦略に組み込むなど、前立腺の健康に対するいくつかの総合的なアプローチを採用するようになってきています。この変化により、早期発見と個別化治療計画の重要性が強調され、予防医療におけるPSA検査の需要がさらに高まっています。

前立腺の健康に関する科学的理解が進むにつれて、研究者は革新的な治療法や薬剤の開発に注力しています。例えば、2023年11月、第3相EMBARK試験の結果に基づき、アステラス製薬とファイザーは、前立腺がん患者に対する有望な治療選択肢であるXTANDI（R）（エンザルタミド）の追加新薬承認申請を米国FDAから受領しました。したがって、正確な診断が治療効果のモニタリングに不可欠であることから、このような研究開発努力と連動してPSA検査に対するニーズが高まっています。

PSA検査産業は、検査タイプ、用途、最終用途、地域に区分されます。

検査タイプに基づくと、確認検査セグメントの市場規模は2023-2032年にCAGR 8.7％を獲得すると予測されています。PCA3や生検を含む確認検査は、PSA値の上昇が検出された後に正確で決定的な結果を提供するために不可欠です。精密医療と個別化された治療計画が重視されるようになっていることも、前立腺の健康診断における確認検査の重要性を高めています。さらに、ヘルスケアプロバイダーによる包括的診断アプローチの採用が増加していることも、このセグメントの成長を後押しします。

最終用途別では、病院セグメントの前立腺特異抗原（PSA）検査産業は、2023年から2032年にかけて8.3％の成長率が見込まれています。病院は、その包括的な医療インフラにより、PSA検査を含む診断処置の主要拠点として機能しています。前立腺関連疾患の罹患率の上昇や高齢化人口の増加も、定期的なPSA検査需要の増加に寄与しています。さらに、病院内での早期発見やがん予防プログラムが重視されていることも、同分野の成長を後押ししています。

地域別では、アジア太平洋地域のPSA検査産業は2022年にかなりの収益シェアを占め、2032年までの成長率は9％を超えると予測されています。意識の高まり、高齢化人口の増加、前立腺関連疾患の有病率の増加が、この地域におけるPSA検査の需要を促進しています。さらに、政府やヘルスケア機関が早期発見とスクリーニングプログラムを積極的に推進しています。診断方法の技術的進歩や男性の健康重視の高まりも、PSA検査の採用拡大に寄与するであろう。

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 前立腺特異抗原（PSA）検査業界考察

• エコシステム分析
• 業界への影響要因
  • 促進要因
    • 前立腺がんの罹患率の増加
    • 高齢者人口の増加
    • PSA検査の技術的進歩
  • 業界の潜在的リスク＆課題
    • PSA検査の高コスト
• 成長可能性分析
• COVID-19影響分析
• 技術情勢
• 規制状況
• 償還シナリオ
• ギャップ分析
• ポーター分析
• PESTEL分析

第4章 競合情勢

• イントロダクション
• 企業マトリックス分析
• 主要市場プレーヤーの競合分析
• 競合のポジショニングマトリックス
• ベンダー・マトリックス分析
• 戦略ダッシュボード

第5章 前立腺特異抗原（PSA）検査市場規模・予測：検査タイプ別、2018年～2032年

• 主要動向：検査タイプ別
• 予備検査
  • 全前立腺特異抗原（PSA）検査
  • 複合型前立腺特異抗原（PSA）検査
  • 遊離前立腺特異抗原（PSA）検査
• 確認検査
  • PCA3検査
  • 経直腸超音波検査
  • 生検

第6章 前立腺特異抗原（PSA）検査市場規模・予測：用途別、2018年～2032年

• 主要動向：用途別
• 前立腺がんスクリーニング
• 前立腺がんモニタリング

第7章 前立腺特異抗原（PSA）検査の市場規模・予測：最終用途別、2018-2032年

• 主要動向：最終用途別
• 病院
• 診断センター
• 専門クリニック
• その他のエンドユーザー

第8章 前立腺特異抗原（PSA）検査市場規模・予測：地域別、2018-2032年

• 主要動向：地域別
• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • メキシコ
  • アルゼンチン
  • その他ラテンアメリカ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • アラブ首長国連邦
  • その他中東とアフリカ

第9章 企業プロファイル

• Abbott Laboratories Inc.
• AdvaCare Pharma
• Bayer AG
• Bio-Rad Laboratories, Inc.
• Beckman Coulter, Inc.
• FUJIREBIO is an H.U. Group company.
• GE HealthCare.
• Abcam plc.
• Lomina AG.
• Laboratory Corporation of America Holdings

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by test type (2022)
• TABLE 3 Market revenue, by application (2022)
• TABLE 4 Market share, by end-use (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global prostate-specific antigen test market size, 2018-2024 (USD Million)
• TABLE 7 Global prostate-specific antigen test market size, 2025-2032 (USD Million)
• TABLE 8 Global prostate-specific antigen test market size, by region, 2018-2024 (USD Million)
• TABLE 9 Global prostate-specific antigen test market size, by region, 2025-2032 (USD Million)
• TABLE 10 Global prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 11 Global prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 12 Global prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 13 Global prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 14 Global prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 15 Global prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 16 Industry impact forces
• TABLE 17 Preliminary tests market size, 2018-2024 (USD Million)
• TABLE 18 Preliminary tests market size, 2025-2032 (USD Million)
• TABLE 19 Total prostate specific antigen test market size, 2018-2024 (USD Million)
• TABLE 20 Total prostate specific antigen test market size, 2025-2032 (USD Million)
• TABLE 21 Complex prostate specific antigen test market size, 2018-2024 (USD Million)
• TABLE 22 Complex prostate specific antigen test market size, 2025-2032 (USD Million)
• TABLE 23 Free prostate specific antigen test market size, 2018-2024 (USD Million)
• TABLE 24 Free prostate specific antigen test market size, 2025-2032 (USD Million)
• TABLE 25 Confirmatory tests market size, 2018-2024 (USD Million)
• TABLE 26 Confirmatory tests market size, 2025-2032 (USD Million)
• TABLE 27 PCA3 Test market size, 2018-2024 (USD Million)
• TABLE 28 PCA3 Test market size, 2025-2032 (USD Million)
• TABLE 29 Trans-rectal ultrasound market size, 2018-2024 (USD Million)
• TABLE 30 Trans-rectal ultrasound market size, 2025-2032 (USD Million)
• TABLE 31 Biopsy market size, 2018-2024 (USD Million)
• TABLE 32 Biopsy market size, 2025-2032 (USD Million)
• TABLE 33 Prostate cancer screening market size, 2018-2024 (USD Million)
• TABLE 34 Prostate cancer screening market size, 2025-2032 (USD Million)
• TABLE 35 Prostate cancer monitoring market size, 2018-2024 (USD Million)
• TABLE 36 Prostate cancer monitoring market size, 2025-2032 (USD Million)
• TABLE 37 Hospitals market size, 2018-2024 (USD Million)
• TABLE 38 Hospitals market size, 2025-2032 (USD Million)
• TABLE 39 Diagnostic centers market size, 2018-2024 (USD Million)
• TABLE 40 Diagnostic centers market size, 2025-2032 (USD Million)
• TABLE 41 Specialty clinics market size, 2018-2024 (USD Million)
• TABLE 42 Specialty clinics market size, 2025-2032 (USD Million)
• TABLE 43 Other end-users market size, 2018-2024 (USD Million)
• TABLE 44 Other end-users market size, 2025-2032 (USD Million)
• TABLE 45 North America prostate-specific antigen test market size, by country, 2018-2024 (USD Million)
• TABLE 46 North America prostate-specific antigen test market size, by country, 2025-2032 (USD Million)
• TABLE 47 North America prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 48 North America prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 49 North America prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 50 North America prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 51 North America prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 52 North America prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 53 North America prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 54 North America prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 55 North America prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 56 North America prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 57 U.S. prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 58 U.S. prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 59 U.S. prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 60 U.S. prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 61 U.S. prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 62 U.S. prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 63 U.S. prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 64 U.S. prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 65 U.S. prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 66 U.S. prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 67 Canada prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 68 Canada prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 69 Canada prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 70 Canada prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 71 Canada prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 72 Canada prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 73 Canada prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 74 Canada prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 75 Canada prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 76 Canada prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 77 Europe prostate-specific antigen test market size, by country, 2018-2024 (USD Million)
• TABLE 78 Europe prostate-specific antigen test market size, by country, 2025-2032 (USD Million)
• TABLE 79 Europe prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 80 Europe prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 81 Europe prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 82 Europe prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 83 Europe prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 84 Europe prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 85 Europe prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 86 Europe prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 87 Europe prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 88 Europe prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 89 Germany prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 90 Germany prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 91 Germany prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 92 Germany prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 93 Germany prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 94 Germany prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 95 Germany prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 96 Germany prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 97 Germany prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 98 Germany prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 99 UK prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 100 UK prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 101 UK prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 102 UK prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 103 UK prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 104 UK prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 105 UK prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 106 UK prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 107 UK prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 108 UK prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 109 France prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 110 France prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 111 France prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 112 France prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 113 France prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 114 France prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 115 France prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 116 France prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 117 France prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 118 France prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 119 Italy prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 120 Italy prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 121 Italy prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 122 Italy prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 123 Italy prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 124 Italy prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 125 Italy prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 126 Italy prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 127 Italy prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 128 Italy prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 129 Spain prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 130 Spain prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 131 Spain prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 132 Spain prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 133 Spain prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 134 Spain prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 135 Spain prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 136 Spain prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 137 Spain prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 138 Spain prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 139 Rest of Europe prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 140 Rest of Europe prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 141 Rest of Europe prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 142 Rest of Europe prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 143 Rest of Europe prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 144 Rest of Europe prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 145 Rest of Europe prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 146 Rest of Europe prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 147 Rest of Europe prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 148 Rest of Europe prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 149 Asia Pacific prostate-specific antigen test market size, by country, 2018-2024 (USD Million)
• TABLE 150 Asia Pacific prostate-specific antigen test market size, by country, 2025-2032 (USD Million)
• TABLE 151 Asia Pacific prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 152 Asia Pacific prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 153 Asia Pacific prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 154 Asia Pacific prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 155 Asia Pacific prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 156 Asia Pacific prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 157 Asia Pacific prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 158 Asia Pacific prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 159 Asia Pacific prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 160 Asia Pacific prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 161 Japan prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 162 Japan prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 163 Japan prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 164 Japan prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 165 Japan prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 166 Japan prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 167 Japan prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 168 Japan prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 169 Japan prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 170 Japan prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 171 China prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 172 China prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 173 China prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 174 China prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 175 China prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 176 China prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 177 China prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 178 China prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 179 China prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 180 China prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 181 India prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 182 India prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 183 India prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 184 India prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 185 India prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 186 India prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 187 India prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 188 India prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 189 India prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 190 India prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 191 Australia prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 192 Australia prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 193 Australia prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 194 Australia prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 195 Australia prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 196 Australia prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 197 Australia prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 198 Australia prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 199 Australia prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 200 Australia prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 201 South Korea prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 202 South Korea prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 203 South Korea prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 204 South Korea prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 205 South Korea prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 206 South Korea prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 207 South Korea prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 208 South Korea prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 209 South Korea prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 210 South Korea prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 211 Rest of Asia Pacific prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 212 Rest of Asia Pacific prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 213 Rest of Asia Pacific prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 214 Rest of Asia Pacific prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 215 Rest of Asia Pacific prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 216 Rest of Asia Pacific prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 217 Rest of Asia Pacific prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 218 Rest of Asia Pacific prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 219 Rest of Asia Pacific prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 220 Rest of Asia Pacific prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 221 Latin America prostate-specific antigen test market size, by country, 2018-2024 (USD Million)
• TABLE 222 Latin America prostate-specific antigen test market size, by country, 2025-2032 (USD Million)
• TABLE 223 Latin America prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 224 Latin America prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 225 Latin America prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 226 Latin America prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 227 Latin America prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 228 Latin America prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 229 Latin America prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 230 Latin America prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 231 Latin America prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 232 Latin America prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 233 Brazil prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 234 Brazil prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 235 Brazil prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 236 Brazil prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 237 Brazil prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 238 Brazil prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 239 Brazil prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 240 Brazil prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 241 Brazil prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 242 Brazil prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 243 Mexico prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 244 Mexico prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 245 Mexico prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 246 Mexico prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 247 Mexico prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 248 Mexico prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 249 Mexico prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 250 Mexico prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 251 Mexico prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 252 Mexico prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 253 Argentina prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 254 Argentina prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 255 Argentina prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 256 Argentina prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 257 Argentina prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 258 Argentina prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 259 Argentina prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 260 Argentina prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 261 Argentina prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 262 Argentina prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 263 Rest of Latin America prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 264 Rest of Latin America prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 265 Rest of Latin America prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 266 Rest of Latin America prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 267 Rest of Latin America prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 268 Rest of Latin America prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 269 Rest of Latin America prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 270 Rest of Latin America prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 271 Rest of Latin America prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 272 Rest of Latin America prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 273 Middle East & Africa prostate-specific antigen test market size, by country, 2018-2024 (USD Million)
• TABLE 274 Middle East & Africa prostate-specific antigen test market size, by country, 2025-2032 (USD Million)
• TABLE 275 Middle East & Africa prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 276 Middle East & Africa prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 277 Middle East & Africa prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 278 Middle East & Africa prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 279 Middle East & Africa prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 280 Middle East & Africa prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 281 Middle East & Africa prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 282 Middle East & Africa prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 283 Middle East & Africa prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 284 Middle East & Africa prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 285 South Africa prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 286 South Africa prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 287 South Africa prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 288 South Africa prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 289 South Africa prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 290 South Africa prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 291 South Africa prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 292 South Africa prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 293 South Africa prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 294 South Africa prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 295 Saudi Arabia prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 296 Saudi Arabia prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 297 Saudi Arabia prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 298 Saudi Arabia prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 299 Saudi Arabia prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 300 Saudi Arabia prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 301 Saudi Arabia prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 302 Saudi Arabia prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 303 Saudi Arabia prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 304 Saudi Arabia prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 305 UAE prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 306 UAE prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 307 UAE prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 308 UAE prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 309 UAE prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 310 UAE prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 311 UAE prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 312 UAE prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 313 UAE prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 314 UAE prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)
• TABLE 315 Rest of Middle East & Africa prostate-specific antigen test market size, by test type, 2018-2024 (USD Million)
• TABLE 316 Rest of Middle East & Africa prostate-specific antigen test market size, by test type, 2025-2032 (USD Million)
• TABLE 317 Rest of Middle East & Africa prostate-specific antigen test market size, by preliminary tests, 2018-2024 (USD Million)
• TABLE 318 Rest of Middle East & Africa prostate-specific antigen test market size, by preliminary tests, 2025-2032 (USD Million)
• TABLE 319 Rest of Middle East & Africa prostate-specific antigen test market size, by confirmatory tests, 2018-2024 (USD Million)
• TABLE 320 Rest of Middle East & Africa prostate-specific antigen test market size, by confirmatory tests, 2025-2032 (USD Million)
• TABLE 321 Rest of Middle East & Africa prostate-specific antigen test market size, by application, 2018-2024 (USD Million)
• TABLE 322 Rest of Middle East & Africa prostate-specific antigen test market size, by application, 2025-2032 (USD Million)
• TABLE 323 Rest of Middle East & Africa prostate-specific antigen test market size, by end-use, 2018-2024 (USD Million)
• TABLE 324 Rest of Middle East & Africa prostate-specific antigen test market size, by end-use, 2025-2032 (USD Million)

Charts & Figures

• FIG. 1 Industry segmentation
• FIG. 2 Top-down approach
• FIG. 3 Market estimation and forecast
• FIG. 4 Market forecasting methodology
• FIG. 5 Breakdown of primary participants
• FIG. 6 Prostate-specific antigen test industry, 360 degree synopsis, 2018 - 2032
• FIG. 7 Industry landscape, 2018-2032 (USD Million)
• FIG. 8 Growth potential analysis, by test type
• FIG. 9 Growth potential analysis, by application
• FIG. 10 Growth potential analysis, by end-use
• FIG. 11 Gap analysis
• FIG. 12 Porter's analysis
• FIG. 13 PESTEL analysis
• FIG. 14 Company matrix analysis, 2022
• FIG. 15 Competitive positioning matrix analysis
• FIG. 16 Strategy dashboard, 2022

Prostate-Specific Antigen Test Market size is set to expand at 8.3% CAGR from 2023 to 2032, driven by the ongoing shift towards comprehensive diagnostic approaches, including confirmatory tests. Of late, healthcare providers worldwide are increasingly embracing several holistic approaches to prostate health, such as integrating prostate-specific antigen (PSA) testing into broader diagnostic strategies. This shift is emphasizing the significance of early detection and personalized treatment plans, further surging the demand for PSA tests in preventive care.

With rising advances in scientific understanding of prostate health, researchers are focusing on developing innovative therapies and drugs. For instance, in November 2023, based on the outcomes of the Phase 3 EMBARK trial, Astellas Pharma and Pfizer received approval from the U.S. FDA for a supplemental New Drug Application for XTANDI® (enzalutamide), a promising treatment option for prostate cancer patients. The need for PSA tests is hence rising in tandem with such R&D efforts as accurate diagnostics are essential for monitoring treatment efficacy.

The PSA test industry is segmented into test type, application, end-use, and region.

Based on test type, the market size from the confirmatory segment is anticipated to gain 8.7% CAGR from 2023-2032. Confirmatory tests, including PCA3 and biopsy, are essential in providing accurate and conclusive results after an elevated PSA level is detected. The growing emphasis on precision medicine and personalized treatment plans is also enhancing the significance of confirmatory tests in prostate health diagnostics. Moreover, the growing adoption of comprehensive diagnostic approaches by healthcare providers will fuel the segment growth.

In terms of end-use, the prostate-specific antigen test industry from the hospitals segment is expected to witness 8.3% growth rate between 2023 and 2032. Hospitals serve as primary hubs for diagnostic procedures, including PSA testing, due to their comprehensive healthcare infrastructure. The rising incidence of prostate-related disorders and the increasing aging population are also contributing to the increasing demand for routine PSA screenings. Furthermore, the emphasis on early detection and cancer prevention programs within hospital settings will boost the segment growth.

Regionally, the Asia Pacific PSA test industry held sizable revenue share in 2022 and is poised to depict over 9% growth rate through 2032. Increasing awareness, the rising aging population, and the growing prevalence of prostate-related disorders are driving the demand for PSA testing in the region. Additionally, governments and healthcare organizations are actively promoting early detection and screening programs. Technological advancements in diagnostic procedures and the greater emphasis on men health will also contribute to the expanding adoption of PSA tests.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definition
• 1.2 Base estimates & working
• 1.3 Data collection
• 1.4 Base estimates & workings
• 1.5 Forecast calculations
• 1.6 Data Sources
  • 1.6.1 Primary
  • 1.6.2 Secondary
    • 1.6.2.1 Paid sources
    • 1.6.2.2 Unpaid sources

Chapter 2 Executive Summary

• 2.1 Global prostate-specific antigen test market 360° synopsis, 2018 - 2032
  • 2.1.1 Business trends
  • 2.1.2 Regional trends
  • 2.1.3 Test type trends
  • 2.1.4 Application trends
  • 2.1.5 End-use trends

Chapter 3 Prostate-Specific Antigen Test Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of prostate cancer
    • 3.2.1.2 Growing geriatric population
    • 3.2.1.3 Technological advancements in PSA testing
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost of PSA testing
• 3.3 Growth potential analysis
  • 3.3.1 By test type
  • 3.3.2 By application
  • 3.3.3 By end-use
• 3.4 COVID- 19 impact analysis
• 3.5 Technology landscape
• 3.6 Regulatory landscape
• 3.7 Reimbursement scenario
• 3.8 Gap analysis
• 3.9 Porter's analysis
• 3.10 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Competitive analysis of major market players, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Vendor matrix analysis, 2022
• 4.6 Strategy dashboard, 2022

Chapter 5 Prostate-Specific Antigen Test Market Size and Forecast, By Test Type, 2018-2032 (USD Million)

• 5.1 Key trends, by test type
• 5.2 Preliminary tests
  • 5.2.1 Total prostate specific antigen test
  • 5.2.2 Complex prostate specific antigen test
  • 5.2.3 Free prostate specific antigen test
• 5.3 Confirmatory tests
  • 5.3.1 PCA3 test
  • 5.3.2 Trans-rectal ultrasound
  • 5.3.3 Biopsy

Chapter 6 Prostate-Specific Antigen Test Market Size and Forecast, By Application, 2018-2032 (USD Million)

• 6.1 Key trends, by application
• 6.2 Prostate cancer screening
• 6.3 Prostate cancer monitoring

Chapter 7 Prostate-Specific Antigen Test Market Size and Forecast, By End-use, 2018-2032 (USD Million)

• 7.1 Key trends, by end-use
• 7.2 Hospitals
• 7.3 Diagnostic centers
• 7.4 Specialty clinics
• 7.5 Other end-users

Chapter 8 Prostate-Specific Antigen Test Market Size and Forecast, By Region, 2018-2032 (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Italy
  • 8.3.5 Spain
  • 8.3.6 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East & Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories Inc.
• 9.2 AdvaCare Pharma
• 9.3 Bayer AG
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Beckman Coulter, Inc.
• 9.6 FUJIREBIO is an H.U. Group company.
• 9.7 GE HealthCare.
• 9.8 Abcam plc.
• 9.9 Lomina AG.
• 9.10 Laboratory Corporation of America Holdings